Notícias do Mercado de Ações

Últimas notícias financeiras · Atualizado Mai 23, 2026

▬ mixed

EUA 'Apenas Tem Certeza de Ter Destruído Um Terço' Dos Mísseis do Irã

US 'Only Certain Of Having Destroyed A Third' Of Iran's Missiles

The panel consensus is that the conflict has multiple rounds ahead, with Iran potentially reserving high-tech missiles. The rapid consumption …

ZeroHedge · Mar 28, 2026
NVDA
▬ mixed

Investidores Estão Completamente Errados Sobre a Ação da Nvidia

Investors Are Completely Wrong About Nvidia Stock

The panel generally agrees that the article in question is promotional and lacks substantial analysis, with most participants taking a …

Nasdaq · Mar 28, 2026
▬ mixed

'No Kings' Rallies Erupt Nationwide

The panel discusses massive protests, but the scale and economic impact remain unverified. While some see political risks for private …

ZeroHedge · Mar 28, 2026
▬ mixed

Fannie Mae Pronta a Aceitar Cripto Como Garantia Para Empréstimos Imobiliários Pela Primeira Vez

Fannie Mae Set To Accept Crypto As Collateral For Home Loans For First Time

The panel is largely bearish on Fannie Mae accepting BTC or USDC as collateral for mortgages due to high volatility …

ZeroHedge · Mar 28, 2026
▬ mixed

Johnson & Johnson Reporta Fortes Resultados a Longo Prazo Para ICOTYDE Em Psoríase em Placas

Johnson & Johnson Reports Strong Long-Term Results For ICOTYDE In Plaque Psoriasis

JNJ's ICOTYDE shows promising durability and safety in treating psoriasis, but its market potential is debated due to competition and …

Nasdaq · Mar 28, 2026
ATEC
▼ bear…

Um VP da Alphatec Vendeu Ações da Empresa no Valor de $1,4 Milhão. Os Investidores Deveriam Evitar a Ação?

An Alphatec VP Sold Company Shares Worth $1.4 Million. Should Investors Avoid the Stock?

The panel is bearish on ATEC due to significant net losses, decelerating growth, insider selling during a downturn, and lack …

Nasdaq · Mar 28, 2026
▬ mixed

Teste HI-PEITHO da Boston Scientific Mostra Sistema EKOS Superior no Tratamento de Embolia Pulmonar Aguda

Boston Scientific HI-PEITHO Trial Shows EKOS System Superior In Acute Pulmonary Embolism Treatment

The panel is divided on the implications of BSX's HI-PEITHO trial success for its EKOS system in intermediate-risk pulmonary embolism. …

Nasdaq · Mar 28, 2026
ADBE
▬ mixed

O crescimento da IA da Adobe assume o centro do palco após o aumento da previsão.

Adobe’s AI growth takes center stage after guidance raise

The panel is divided on Adobe's valuation, with concerns about AI monetization, margin erosion, and execution risk, but also potential …

Yahoo Finance · Mar 28, 2026
ASTS
▼ bear…

Aqui está o que os investidores precisam saber sobre o recuo recente das ações da AST SpaceMobile

Here's What Investors Need to Know About AST SpaceMobile Stock's Recent Pullback

The panel consensus is overwhelmingly bearish on AST SpaceMobile, citing high valuation, cash burn, lack of profitability timeline, and significant …

Yahoo Finance · Mar 28, 2026
SNY
▬ mixed

Sanofi Relata Resultados Positivos da Fase 3 Para Amlitelimab Em Dermatite Atópica

Sanofi Reports Positive Phase 3 Results For Amlitelimab In Atopic Dermatitis

Sanofi's amlitelimab showed mixed Phase 3 results, meeting primary endpoints in two trials but failing to reach statistical significance on …

Nasdaq · Mar 28, 2026
▬ mixed

Como Converter Seu 401(k) Em Um Pagamento Mensal Confiável

How To Convert Your 401(k) Into A Reliable Monthly Paycheck

The panel consensus is that the standard retirement income playbook, as outlined in the article, is insufficient for today's retirees …

ZeroHedge · Mar 28, 2026
▬ mixed

‘Parece que estão a inventar números do nada’: Proprietários de animais de estimação do Reino Unido celebram a repressão às taxas veterinárias

‘It feels like they’re pulling figures out of the sky’: UK pet owners welcome crackdown on vet fees

The CMA's intervention, while targeting market failures, may have limited impact due to practices shifting costs and the lack of …

The Guardian · Mar 28, 2026